The Truncated Isoform of Somatostatin Receptor5 (sst5TMD4) Is Associated with Poorly Differentiated Thyroid Cancer

Ítems similars

• Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas
  per: Luque, Raúl M., et al.
  Publicat: (2015)
• Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors
  per: Sampedro-Núñez, Miguel, et al.
  Publicat: (2015)
• The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients
  per: Gahete, Manuel D., et al.
  Publicat: (2016)
• Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5
  per: Cordelier, Pierre, et al.
  Publicat: (1997)
• Selective Somatostatin 5 (SST5) and Somatostatin 2 (SST2) Nonpeptide Agonists Potently Suppress Glucose- and Tolbutamide-Stimulated Dynamic Insulin Secretion From Isolated Human Islets
  per: Rico, Elizabeth, et al.
  Publicat: (2021)